Investor Relations

Company Overview

ProPhase Labs (NASDAQ: PRPH) is a diversified medical science and technology company. The Company’s laboratory testing subsidiary, ProPhase Diagnostics, offers SARS-CoV-2 (COVID-19) and COVID-19 viral mutation PCR tests through both saliva and nasal swab methods at its CLIA certified laboratories. Critical to COVID testing, results are typically provided in under 24 hours. ProPhase Labs also has deep experience with OTC consumer healthcare products and dietary supplements.